首页> 外文OA文献 >Overcoming primary and acquired erlotinib resistance with epidermal growth factor receptor (EGFR) and phosphoinositide 3-kinase (PI3K) co-inhibition in pancreatic cancer

【2h】

Overcoming primary and acquired erlotinib resistance with epidermal growth factor receptor (EGFR) and phosphoinositide 3-kinase (PI3K) co-inhibition in pancreatic cancer

机译：通过表皮生长因子受体（EGFR）和磷酸肌醇3激酶（PI3K）共同抑制胰腺癌克服原发性和获得性厄洛替尼耐药性

页面导航

著录项
相似文献
相关主题

著录项

作者
Wong Matthew Ho Fai;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Combined Erlotinib and Cetuximab overcome the acquired resistance to epidermal growth factor receptors tyrosine kinase inhibitor in non-small-cell lung cancer. [J] . Meng Wang, Jing Zhao, Lian-Min Zhang, Journal of Cancer Research and Clinical Oncology . 2012,第12期

机译：厄洛替尼和西妥昔单抗联合可克服非小细胞肺癌对表皮生长因子受体酪氨酸激酶抑制剂的获得性耐药。
2. Combined Erlotinib and Cetuximab overcome the acquired resistance to epidermal growth factor receptors tyrosine kinase inhibitor in non-small-cell lung cancer [J] . Meng Wang, Jing Zhao, Lian-Min Zhang, Journal of Cancer Research and Clinical Oncology . 2012,第12期

机译：厄洛替尼和西妥昔单抗联合治疗可克服非小细胞肺癌对表皮生长因子受体酪氨酸激酶抑制剂的耐药性
3. Phase I/II Study of HSP90 Inhibitor AUY922 and Erlotinib for EGFR-Mutant Lung Cancer With Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors [J] . Johnson Melissa L., Yu Helena A., Hart Eric M., Journal of Clinical Oncology . 2015,第15期

机译：HSP90抑制剂AUY922和Erlotinib用于对表皮生长因子受体酪氨酸激酶抑制剂具有耐药性的EGFR突变型肺癌的I / II期研究
4. Targeting of Epidermal Growth Factor Receptor (EGFR)-positive pancreatic cancer cell lines with cetuximab-conjugated near-infrared silver sulphide quantum dots [C] . Peter L. Labib, Elnaz Yaghini, Mahshid Hashemkhani, International Photodynamic Association World Congress;Society of Photo-Optical Instrumentation Engineers;International Photodynamic Association . 2019

机译：西妥昔单抗缀合的近红外硫化银量子点靶向表皮生长因子受体（EGFR）阳性胰腺癌细胞系
5. Overcoming Anti-Estrogen Resistance in Estrogen Receptor (ER)-Positive Breast Cancer: Rational Targeting of Phosphatidylinositol 3-Kinase (PI3K) and the Resurrection of Estrogen Therapy [D] . Hosford, Sarah 2018

机译：克服雌激素受体（ER）阳性乳腺癌中的抗雌激素抵抗：磷脂酰肌醇3-激酶（PI3K）的合理靶向和雌激素疗法的复活
6. Epidermal Growth Factor Reverses the Inhibitory Effects of the Bisphosphonate Zoledronic Acid on Human Oral Keratinocytes and Human Vascular Endothelial Cells In Vitro via the Epidermal Growth Factor Receptor (EGFR)/Akt/Phosphoinositide 3-Kinase (PI3K) Signaling Pathway [O] . Qizhang Wang, Jiyuan Liu, Ting Guo, 2019

机译：表皮生长因子通过表皮生长因子受体（EGFR）/ Akt /磷酸肌醇3-激酶（PI3K）信号通路逆转双膦酸盐唑来膦酸对人口腔角质形成细胞和人血管内皮细胞的抑制作用。
7. Phosphoinositide 3-kinase (PI3K); HER2 (EGFR2; ERBB2; neu); epidermal growth factor receptor 3 (EGFR3; HER3; ERBB3) [O] . 2011

机译：磷酸钠3-激酶（PI3K）; HER2（EGFR2; ERBB2; NEU）;表皮生长因子受体3（EGFR3; HER3; ERBB3）

Overcoming primary and acquired erlotinib resistance with epidermal growth factor receptor (EGFR) and phosphoinositide 3-kinase (PI3K) co-inhibition in pancreatic cancer

著录项

相似文献

相关主题

期刊订阅